Millennium Management’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Millennium Management’s Portfolio BIOT Stock Details BIOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-146,293	Closed	-$96K	–	7905
2021 Q4	$96K	Sell	146,293 -1,707	-1%	-$16.8K	﹤0.01%	6274
2021 Q3	$98K	Buy	148,000 +48,000	+48%	+$465K	﹤0.01%	6448
2021 Q2	$86K	Buy	+100,000	New	+$972K	﹤0.01%	6268

Millennium Management's BIOT Position: Q1 2023 in Review

Millennium Management sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q1 2023, closing a stake of 706,893 shares — an estimated $7.14M sold.

Millennium Management first reported a position in BIOT in Q2 2021 and held it in 7 quarters. The position peaked at $7.14M in Q4 2022. 0 funds tracked by Wall St. Rank hold BIOT as of Q1 2023.

Millennium Management reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Millennium Management sold 706,893 Biotech Acquisition Company Class A Ordinary Shares shares in Q1 2023, an estimated $7.14M.
Millennium Management first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q2 2021 and held it in 7 quarters.
Millennium Management's Biotech Acquisition Company Class A Ordinary Shares position peaked at $7.14M in Q4 2022.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.